4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001415889-24-029162
Chief Business Officer sold 50,000 shares at $13.15 ($657,625)
- Chief Business Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chakma Justin Chief Business Officer | 2024-12-10 | Option exercise | +50,000 | $0.84 | $42,000 | 186,380 | D |
| Chakma Justin Chief Business Officer | 2024-12-10 | Sale | −50,000 | $13.15 | $657,625 | 136,380 | D |
| Derivatives | |||||||
| Chakma Justin Chief Business Officer | 2024-12-10 | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | D | ||
| Open-market sales · 50,000 sh · avg $13.15 · $657,625 | |||||||
Loading xslF345X05/form4-12122024_101220.xml…